Investment
Features
FeesSafety
Academy
More
Pluang+

Compare United States Brent Oil Fund LP (BNO) vs Vertex Pharmaceuticals Incorporated (VRTX) Price & Performance

United States Brent Oil Fund LPTrade
Vertex Pharmaceuticals IncorporatedTrade

Price performance (Past 24H)

Key statistics

United States Brent Oil Fund LP vs Vertex Pharmaceuticals Incorporated — how do they compare? United States Brent Oil Fund LP trades at $50.88, while Vertex Pharmaceuticals Incorporated trades at $529.98 (market cap $134.25B). The key difference: Vertex Pharmaceuticals Incorporated is trading nearer its 52-week high, United States Brent Oil Fund LP nearer its low. Which is the better fit depends on your goals.

BNOVRTX
Sector
Commodities - EnergyHealth
52-Week High
$60.13$529.65
52-Week Low
$27.20$376.62
Market Cap
$134.25B
Enterprise Value
$128.37B

Returns comparison

Trailing returns across standard periods

About United States Brent Oil Fund LP

BNO is a commodity ETF that tracks the daily price of Brent crude oil futures. It provides exposure to the international oil benchmark, which often trades at a premium to the U.S. WTI benchmark, and is primarily used for short-term trading due to roll costs.

Read more on BNO

About Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Read more on VRTX